The Vanguard Group 13D/13G Filings for Eton Pharmaceuticals, Inc. (ETON)

The Vanguard Group 13D and 13G filings for Eton Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-30
3:18 pm
Purchase
2025-09-3013GEton Pharmaceuticals, Inc.
ETON
The Vanguard Group1,344,115
5.010%
1,344,115increase
(New Position)
Filing